Renaud Ronald C Jr - Net Worth and Insider Trading
Renaud Ronald C Jr Net Worth
The estimated net worth of Renaud Ronald C Jr is at least $4 Million dollars as of 2024-05-02. Renaud Ronald C Jr is the President & CEO of Cerevel Therapeutics Holdings Inc and owns about 83,857 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $4 Million. Renaud Ronald C Jr is also the CEO of Translate Bio Inc and owns about 0 shares of Translate Bio Inc (TBIO) stock worth over $0. Details can be seen in Renaud Ronald C Jr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Renaud Ronald C Jr has not made any transactions after 2023-08-03 and currently still holds the listed stock(s).
Transaction Summary of Renaud Ronald C Jr
Renaud Ronald C Jr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Renaud Ronald C Jr owns 8 companies in total, including Atara Biotherapeutics Inc (ATRA) , Translate Bio Inc (TBIO) , and Chimerix Inc (CMRX) among others .
Click here to see the complete history of Renaud Ronald C Jr’s form 4 insider trades.
Insider Ownership Summary of Renaud Ronald C Jr
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATRA | Atara Biotherapeutics Inc | 2021-06-08 | director |
TBIO | Translate Bio Inc | 2021-09-14 | director & Chief Executive Officer & other: President |
CMRX | Chimerix Inc | 2014-12-17 | director |
2014-09-12 | director | ||
2017-01-03 | director | ||
2007-02-14 | Chief Financial Officer | ||
2021-03-25 | director | ||
2023-08-03 | director & President & CEO |
Renaud Ronald C Jr Latest Holdings Summary
Renaud Ronald C Jr currently owns a total of 2 stocks. Among these stocks, Renaud Ronald C Jr owns 83,857 shares of Cerevel Therapeutics Holdings Inc (CERE) as of August 3, 2023, with a value of $4 Million and a weighting of 100%. Renaud Ronald C Jr also owns 0 shares of Translate Bio Inc (TBIO) as of September 14, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Renaud Ronald C Jr
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CERE | Cerevel Therapeutics Holdings Inc | 2023-08-03 | 83,857 | 42.60 | 3,572,308 |
TBIO | Translate Bio Inc | 2021-09-14 | 0 | 37.36 | 0 |
Holding Weightings of Renaud Ronald C Jr
Renaud Ronald C Jr Form 4 Trading Tracker
According to the SEC Form 4 filings, Renaud Ronald C Jr has made a total of 1 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the acquisition of 83,857 shares on August 3, 2023, which cost Renaud Ronald C Jr around $2 Million.
According to the SEC Form 4 filings, Renaud Ronald C Jr has made a total of 1 transactions in Translate Bio Inc (TBIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Translate Bio Inc is the sale of 954,053 shares on September 14, 2021, which brought Renaud Ronald C Jr around $36 Million.
Insider Trading History of Renaud Ronald C Jr
- 1
Renaud Ronald C Jr Trading Performance
GuruFocus tracks the stock performance after each of Renaud Ronald C Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renaud Ronald C Jr is 10.94%. GuruFocus also compares Renaud Ronald C Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renaud Ronald C Jr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Renaud Ronald C Jr's insider trading performs compared to the benchmark.
Performance of Renaud Ronald C Jr
Renaud Ronald C Jr Ownership Network
Ownership Network List of Renaud Ronald C Jr
Ownership Network Relation of Renaud Ronald C Jr
Renaud Ronald C Jr Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
Renaud Ronald C Jr is the director of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , SVP & GC & Secretary Amar Murugan , and director & President and CEO Pascal Touchon .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, Renaud Ronald C Jr made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 151,346 shares made by Pascal Touchon , a net sale of 43,245 shares made by Amar Murugan , and a net sale of 34,741 shares made by Eric J Hyllengren .
In summary, during the past 3 months, insiders sold 56,192 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 56,192 shares. During the past 18 months, 337,881 shares of Atara Biotherapeutics Inc (ATRA) were sold and 816,825 shares were bought by its insiders, resulting in a net purchase of 478,944 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
Renaud Ronald C Jr Mailing Address
Above is the net worth, insider trading, and ownership report for Renaud Ronald C Jr. You might contact Renaud Ronald C Jr via mailing address: C/o Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge Ma 02109.